Prophylaxis: Clinical Trials

1 trial for Prophylaxis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Prophylaxis: new trials by email Literature Review of Prophylaxis trials Research Report on Prophylaxis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19)
Hydroxychloroquine - COVID19, Hydroxychloroquine
Phase 2TerminatedIstituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS1552020-05-142025-03-10

Narrower conditions

COVID-19 (1)

Broader conditions

Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nidovirales Infections (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Virus Diseases (1)

Interventions

Hydroxychloroquine (1)

Sponsors

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS (1)

Countries

Italy (1)

Top investigators

Giovanni Martinelli, Prof. (1)  ·  Pierluigi Viale, Prof. (1)

Results publications

PMID 32736597